Abstract Background: Vitiligo is an acquired depigmentation disorder affecting individuals worldwide. The potential link between immunosuppressants and the onset or exacerbation of vitiligo remains a topic of clinical concern. Objective: This study aims to evaluate the association between various immunosuppressants and vitiligo using data from the FDA Adverse Event Reporting System (FAERS).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Bingnan
Contact Bingnan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack